Covid-19

Vaccine vial and syringe
#Covid variants #Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #Omicron

Vaccine monitoring crucial as SARS-CoV-2 evolves

UK researchers have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve. The Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at University College Hospitals London (UCLH) published their… Read More

#News #Trending News

#3D chemistry #AI #Artificial intelligence (AI) #Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #Gene expression #Gene mutation #Interview #mRNA #Next generation sequencing #Oncology #PharmEnable #RNA sequencing #Single-cell RNA sequencing #Vaccines

Podcast: What trends will speed up the journey from clinic to bedside?

This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More

#News

Vaccine discovery
#Covid-19 #Immunity #Immunology / Virology & Vaccines #Pandemic prevention #Vaccines

Accelerating recombinant protein vaccine discovery

Listen to this article on the DDW Podcast: Vaccination responses need to be rapid, efficacious and cost-effective if they are to outpace new viral threats emerging across the globe, says Jian He (Jason), Chemistry, Manufacturing and Controls (CMC) Head, WuXi Vaccines. Technologies that hasten the pathway from vaccine discovery to… Read More

#Exclusive Content

#Covid-19 #Immune system #Immunity #Immunology / Virology & Vaccines #Influenza #Stem cell transplant #TB vaccine

New DDW Highlights podcast: 22 January 2024

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With seasonal illnesses running amok in the western hemisphere at the moment, it is… Read More

#News

#Covid-19 #Immune system #Immunity #Immunology / Virology & Vaccines #Influenza #Stem cell transplant #TB vaccine

This week in drug discovery (15-19 January) 

News round-up for 15-19 January by DDW Digital Content Editor Diana Spencer. With seasonal illnesses running amok in the western hemisphere at the moment, it is perhaps not surprising that this week’s news highlights focus on viruses and immunity. The top stories: Antibody… Read More

#News

Older adult receiving vaccine
#Covid-19 #Immunity #Immunology / Virology & Vaccines #Influenza #University of Oxford

Collaborative study to improve flu and Covid-19 vaccine design

With funding from MRC/UKRI, the University of Oxford has assembled a team of scientists, radiologists and clinicians to research and understand the cause and effect of varying responses to vaccination. The results will assist researchers in designing vaccines which will offer greater protection to the most… Read More

#News

Covid-19
#Covid variants #Covid-19 #Immunity #Omicron #University College London #University of Glasgow

Revealed: How Covid-19 variants stay ahead of immune defences

Recent SARS-CoV-2 variants such as BA.4 and BA.5 developed abilities missing from the first Omicron variants that allowed them to overcome humans’ innate immunity, according to research from University College London (UCL). The study examined viral evolution in eight Omicron variants to better understand how the… Read More

#News #Trending News

Antibodies attack Covid-19
#Antibodies #Covid variants #Covid-19 #Covid-19 treatment #ExeVir Bio #Omicron

Antibody cocktail effective against emerging Covid-19 variants

Biotech company ExeVir Bio has revealed new data demonstrating that its antibodies are effective in neutralising currently circulating Covid-19 Omicron variants. The company says that all authorised SARS-CoV-2 therapeutic antibodies that have been used in the clinic show severe to complete loss of virus neutralisation potency… Read More

#News

Patient receiving a vaccine
#Covid-19 #Covid-19 vaccine #Immunology / Virology & Vaccines #Long Covid

Covid-19 vaccines found to protect against long Covid

A study has revealed that Covid-19 vaccines are effective in preventing long Covid, but the BioNTech/Pfizer vaccine provided better protection than ChAdOx1, developed by Oxford University/AstraZeneca. A research team at NDORMS (Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences), University of Oxford has found that vaccination… Read More

#News #Trending News

#Cancer research #Clinical trials #Covid-19 #Immunology / Virology & Vaccines #Neuroscience #Oncology

DDW readers’ top drug discovery developments of 2023

DDW’s Diana Spencer takes a look at the breaking news stories that were most popular with DDW readers over the last year. Representing a dominant field of drug discovery, it isn’t surprising that breakthroughs in cancer research were popular with DDW readers in 2023, particularly strategies to overcome treatment resistance… Read More

#Exclusive Content

Vaccine research
#Assays #Covid-19 #Drug efficacy #eBook #Immunology / Virology & Vaccines #Vaccines

eBook: Assessing the efficacy of vaccines through laboratory assays

The eighth eBook of the Hamilton series is now available to download for free. In ‘Assessing the Efficacy of Vaccines through Laboratory Assays‘, the authors discuss the key milestones achieved throughout the history of vaccine development, the laboratory tests commonly used to assess vaccines’ efficacy, and we… Read More

#News

#Assays #Covid-19 #Drug efficacy #Immunology / Virology & Vaccines #Vaccines

Assessing the efficacy of vaccines through laboratory assays

In the eighth eBook of the Hamilton series, ‘Assessing the Efficacy of Vaccines through Laboratory Assays’, we discuss: Vaccine development: Key milestones and impact of Covid-19 Laboratory tests commonly used to assess vaccines’ efficacy and the benefits of automating them Hamilton standardised and customised solutions for workflows such as qPCR,… Read More

#Resources

Covid-19 vaccine
#Covid-19 #Immunology / Virology & Vaccines #University of Queensland

Successful clinical trial for re-engineered Covid vaccine 

The University of Queensland’s re-engineered clamp platform has produced a vaccine that is equally safe and virus-neutralising as an approved Covid vaccine considered among the best in its class. The pivotal proof-of-concept testing clears the way to progress the Clamp2 technology in a range of research programmes.  … Read More

#Covid-19 #News

Target concept
#Biopharma #Covid-19 #Drug discovery

The value of mission-orientated research in biopharma R&D 

Patrick Speedie, Co-Founder & Co-CEO of IN-PART, explores why a global approach is needed for the best science to prosper and the lessons industry can take from the Covid-19 pandemic.    The Covid-19 pandemic unequivocally demonstrated the power of industry-academia collaboration, with the fastest ever development, testing and approval of a… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Big pharma #BioNTech #Biopharmaceuticals #Comirnaty #Covid-19 #Drug discovery #Healthcare #Moderna #mRNA #Pfizer

New podcast on drug discovery trends

This is the latest episode of the free DDW narrated podcast, “Drug discovery trends: From regulation to embracing AI”, which covers two articles written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: From the Editor: Law and order and… Read More

#News

The microbiome
#Alzheimer's #Antibodies #Cancer #Covid-19 #Rare disease #Therapeutic Antibodies

Which diseases will benefit from therapeutic antibody development?

Listen to this article on the DDW Podcast: DDW’s Megan Thomas looks at how different diseases will benefit from the success of therapeutic antibodies. Cancer Monoclonal antibodies (mAbs) are a type of targeted drug therapy, and as such are often used to treat cancer. Alongside surgery, radiation and chemotherapy, antibody-based immunotherapy… Read More

#Exclusive Content